Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

Author:

Ribas Antoni1,Hamid Omid2,Daud Adil3,Hodi F. Stephen4,Wolchok Jedd D.5,Kefford Richard6,Joshua Anthony M.7,Patnaik Amita8,Hwu Wen-Jen9,Weber Jeffrey S.10,Gangadhar Tara C.11,Hersey Peter12,Dronca Roxana13,Joseph Richard W.14,Zarour Hassane15,Chmielowski Bartosz1,Lawrence Donald P.16,Algazi Alain3,Rizvi Naiyer A.5,Hoffner Brianna2,Mateus Christine17,Gergich Kevin18,Lindia Jill A.18,Giannotti Maxine18,Li Xiaoyun Nicole19,Ebbinghaus Scot18,Kang S. Peter18,Robert Caroline17

Affiliation:

1. Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles

2. Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California

3. Department of Hematology/Oncology, University of California-San Francisco, San Francisco

4. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

5. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

6. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia

7. Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

8. Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio

9. Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston

10. Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida

11. Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia

12. Department of Medicine, University of Sydney, Sydney, Australia

13. Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota

14. Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida

15. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

16. Department of Hematology/Oncology, Massachusetts General Hospital, Boston

17. Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France

18. Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey

19. BARDS, Merck & Co, Inc, Kenilworth, New Jersey

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3